Tomoko Iwata-Kajihara

Enhanced Cancer Immunotherapy Using STAT3-Depleted Dendritic Cells with High Th1-Inducing Ability and Resistance to Cancer Cell-Derived Inhibitory Factors

K. Takeda, H. Mizuguchi, M. Miyagishi, 2011, The Journal of Immunology.

The mechanisms of cancer immunoescape and development of overcoming strategies

Y. Kawakami, T. Yaguchi, N. Kawamura, 2011, International journal of hematology.

Cancer‐induced immunosuppressive cascades and their reversal by molecular‐targeted therapy

Y. Kawakami, T. Tsujikawa, T. Yaguchi, 2013, Annals of the New York Academy of Sciences.

Roles of Signaling Pathways in Cancer Cells and Immune Cells in Generation of Immunosuppressive Tumor-Associated Microenvironments

Y. Kawakami, T. Tsujikawa, T. Yaguchi, 2013 .

Improvement of Cancer Immunotherapy by Combining Molecular Targeted Therapy

Y. Kawakami, T. Tsujikawa, B. Popivanova, 2013, Front. Oncol..

Cancer Cell-Derived Inhibitory Factors Th1-Inducing Ability and Resistance to STAT3-Depleted Dendritic Cells with High Enhanced Cancer Immunotherapy Using

K. Takeda, H. Mizuguchi, M. Miyagishi, 2011 .